Moderna uses the right dose of data to boost discovery Cambridge, MA based Moderna believes that messenger RNA, or mRNA, is the “software of life.” Since being founded in 2010, the company has worked to pioneer a new class of medicines based on their extensive research into mRNA. In a highly regulated industry, Moderna knows the critical importance data plays in key processes for the creation, approval, and distribution of vaccines and therapeutics. When the COVID-19 pandemic started in 2020, the pressure to find a fast, effective, and safe vaccine became a global priority. As the need for accurate, auditable, and actionable insights has become greater, Moderna has leveraged its modern, multicloud data stack to prioritize the job at hand. Finding the Best Solution for the Job

Join for free to read